Vol 11, No 3 (2022)

Date published: 2022-06-30

Table of Contents

open access

Editorials

Sojourn of Gemigliptin: A Hidden Gem?

Awadhesh Kumar Singh

Editorial

DOI: 10.5603/DK.a2022.0027
Clinical Diabetology 2022;11(3):131-134.
Original articles

Developing a Minimum Data Set (MDS) for the Management of Diabetic Foot: Basis for Introducing Effective Indicators to the Better Management, Control and Monitoring of Diabetic Foot

Khadijeh Moulaei, Farhad Fatehi, Kambiz Bahaadinbeigy

Research paper

DOI: 10.5603/DK.a2021.0053
Clinical Diabetology 2022;11(3):135-145.

Association between Hyperglycemic Crisis with Major Cardiovascular Events in Patients with Diabetes: A Single Center Retrospective Cohort Study

Ivana Beatrice Paulus, Jourdan Wirasugianto, Ni Luh Putu Putri Sanjiwani, I Gede Putu Supadmanaba, I Made Siswadi Semadi, Ketut Suastika

Research paper

DOI: 10.5603/DK.a2022.0019
Clinical Diabetology 2022;11(3):146-150.

Real World Study of Effectiveness of Gemigliptin Add-On Therapy in Type 2 Diabetes Mellitus

Trisha Sarkar, Debmalya Sanyal, Amalesh Samanta, Sujoy Ghosh

Research paper

DOI: 10.5603/DK.a2022.0014
Clinical Diabetology 2022;11(3):151-155.

Use of a Diabetes Self-Management Application in Combination with a 4 mm Pen Needle and Its Impact on Glycemic Variability and Patient-Reported Outcomes in People with Type 2 Diabetes Using Basal-Bolus Insulin Therapy

Edward Mahoney, Stanislav Glezer, Leah Baccari, Jason Lebowitz, Wen Yue, David Klonoff

Research paper

DOI: 10.5603/DK.a2022.0012
Clinical Diabetology 2022;11(3):156-164.

Efficacy and Safety of Atorvastatin 40 mg versus Rosuvastatin 20 mg in Patients with Type 2 Diabetes Mellitus and Previous Acute Coronary Syndrome: A Randomized Clinical Trial

Abdel-Hameed Ibrahim Mohamed Ebid, Yasmine Magdy Fahim Genina, Abdul-Majeed Abdulfattah Al-Jendy, Amira Mohamed El-Sawy

Research paper

DOI: 10.5603/DK.a2022.0021
Clinical Diabetology 2022;11(3):165-174.

The Correlation between Resilience, Self-efficacy and Illness Perception in Patients with Type 2 Diabetes: A Cross-Sectional Study

Fateme Mohammadi, Banafsheh Tehranineshat, Mojtaba Farjam, Soheila Rahnavard, Mostafa Bijani

Research paper

DOI: 10.5603/DK.a2022.0024
Clinical Diabetology 2022;11(3):175-182.

Psychological Impact of COVID-19 Lockdown on Well-being: Comparisons between People with Obesity, with Diabetes and without Diseases

Verónica Vázquez-Velázquez, José J. Pizarro, Sofia Sánchez Román, Valeria Soto Fuentes, Denise Arcila-Martínez, Hector Velazquez-Jurado

Research paper

DOI: 10.5603/DK.a2022.0020
Clinical Diabetology 2022;11(3):183-191.
Review articles

The Implication of Time-in-Range for the Management of Diabetes in India: A Narrative Review

Sudhir Tripathi, Sushil Jindal, Manoj Chawla, Arvind Gupta, Sujeet Jha, Uday Phadke, Tejal Lathia

Review article

DOI: 10.5603/DK.a2022.0018
Clinical Diabetology 2022;11(3):192-199.

Understanding Medication-Related Belief in Patients with Type 2 Diabetes: a Meta-Analytic Review

Omid Khosravizadeh, Bahman Ahadinezhad, Aisa Maleki, Ailar Hashtroodi, Ali Moqadam, Hamideh Kamali

Metaanalysis

DOI: 10.5603/DK.a2022.0025
Clinical Diabetology 2022;11(3):200-209.
Letters

Features of the Course of Chronic Kidney Disease in Patients with Type 1 and Type 2 Diabetes, Depending on the Level of Amylinemia

Iryna Tsaryk, Nataliia Pashkovska

Observation letter

DOI: 10.5603/DK.a2022.0022
Clinical Diabetology 2022;11(3):210-211.

Association between Red Blood Cell Distribution Width and Retinopathy in Patients with Type 2 Diabetes: A Cross-Sectional Study

Fateme Abshenas, Gholamhosein Yaghoobi, Ali Moradi, Hassan Mehrad-Majd, Mohammad Ali Yaghoubi, Amirhossein Sahebkar

Observation letter

DOI: 10.5603/DK.a2022.0023
Clinical Diabetology 2022;11(3):212-214.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl